Cargando…

Case report: Neoadjuvant systemic therapy for melanoma

We report a case of rapidly enlarging metastatic melanoma in 45-year-old White male following primary resection of thin melanoma five years ago. Location and large size of the lesion possessed significant risk of complications from surgery, therefore provided a challenge in treatment options. Neoadj...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabuniya, Natiya, Khajuria, Ankur, Geh, Jenny L.C., Alsaadi, Daniah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262473/
https://www.ncbi.nlm.nih.gov/pubmed/32489661
http://dx.doi.org/10.1016/j.amsu.2020.05.013
_version_ 1783540632155848704
author Gabuniya, Natiya
Khajuria, Ankur
Geh, Jenny L.C.
Alsaadi, Daniah
author_facet Gabuniya, Natiya
Khajuria, Ankur
Geh, Jenny L.C.
Alsaadi, Daniah
author_sort Gabuniya, Natiya
collection PubMed
description We report a case of rapidly enlarging metastatic melanoma in 45-year-old White male following primary resection of thin melanoma five years ago. Location and large size of the lesion possessed significant risk of complications from surgery, therefore provided a challenge in treatment options. Neoadjuvant targeted chemotherapy was commenced and resulted in a significant reduction in size of the lesion, which allowed subsequent safe surgical resection with no residual disease on histopathology results. This case provides a good example of successful utilization of neoadjuvant systemic therapy in advanced metastatic melanoma.
format Online
Article
Text
id pubmed-7262473
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72624732020-06-01 Case report: Neoadjuvant systemic therapy for melanoma Gabuniya, Natiya Khajuria, Ankur Geh, Jenny L.C. Alsaadi, Daniah Ann Med Surg (Lond) Case Report We report a case of rapidly enlarging metastatic melanoma in 45-year-old White male following primary resection of thin melanoma five years ago. Location and large size of the lesion possessed significant risk of complications from surgery, therefore provided a challenge in treatment options. Neoadjuvant targeted chemotherapy was commenced and resulted in a significant reduction in size of the lesion, which allowed subsequent safe surgical resection with no residual disease on histopathology results. This case provides a good example of successful utilization of neoadjuvant systemic therapy in advanced metastatic melanoma. Elsevier 2020-05-25 /pmc/articles/PMC7262473/ /pubmed/32489661 http://dx.doi.org/10.1016/j.amsu.2020.05.013 Text en © 2020 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Gabuniya, Natiya
Khajuria, Ankur
Geh, Jenny L.C.
Alsaadi, Daniah
Case report: Neoadjuvant systemic therapy for melanoma
title Case report: Neoadjuvant systemic therapy for melanoma
title_full Case report: Neoadjuvant systemic therapy for melanoma
title_fullStr Case report: Neoadjuvant systemic therapy for melanoma
title_full_unstemmed Case report: Neoadjuvant systemic therapy for melanoma
title_short Case report: Neoadjuvant systemic therapy for melanoma
title_sort case report: neoadjuvant systemic therapy for melanoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262473/
https://www.ncbi.nlm.nih.gov/pubmed/32489661
http://dx.doi.org/10.1016/j.amsu.2020.05.013
work_keys_str_mv AT gabuniyanatiya casereportneoadjuvantsystemictherapyformelanoma
AT khajuriaankur casereportneoadjuvantsystemictherapyformelanoma
AT gehjennylc casereportneoadjuvantsystemictherapyformelanoma
AT alsaadidaniah casereportneoadjuvantsystemictherapyformelanoma